» Articles » PMID: 22114101

Factors Related to Morbidity and Mortality in Patients with Chronic Heart Failure with Systolic Dysfunction: the HF-ACTION Predictive Risk Score Model

Abstract

Background: We aimed to develop a multivariable statistical model for risk stratification in patients with chronic heart failure with systolic dysfunction, using patient data that are routinely collected and easily obtained at the time of initial presentation.

Methods And Results: In a cohort of 2331 patients enrolled in the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise TraiNing) study (New York Heart Association class II-IV, left ventricular ejection fraction ≤0.35, randomized to exercise training and usual care versus usual care alone, median follow-up of 2.5 years), we performed risk modeling using Cox proportional hazards models and analyzed the relationship between baseline clinical factors and the primary composite end point of death or all-cause hospitalization and the secondary end point of all-cause death alone. Prognostic relationships for continuous variables were examined using restricted cubic spline functions, and key predictors were identified using a backward variable selection process and bootstrapping methods. For ease of use in clinical practice, point-based risk scores were developed from the risk models. Exercise duration on the baseline cardiopulmonary exercise test was the most important predictor of both the primary end point and all-cause death. Additional important predictors for the primary end point risk model (in descending strength) were Kansas City Cardiomyopathy Questionnaire symptom stability score, higher serum urea nitrogen, and male sex (all P<0.0001). Important additional predictors for the mortality risk model were higher serum urea nitrogen, male sex, and lower body mass index (all P<0.0001).

Conclusions: Risk models using simple, readily obtainable clinical characteristics can provide important prognostic information in ambulatory patients with chronic heart failure with systolic dysfunction.

Clinical Trial Registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00047437.

Citing Articles

The chronic heart failure evolutions: Different fates and routes.

Agostoni P, Chiesa M, Salvioni E, Emdin M, Piepoli M, Sinagra G ESC Heart Fail. 2024; 12(1):418-433.

PMID: 39318188 PMC: 11769638. DOI: 10.1002/ehf2.14966.


A Computable Algorithm for Medication Optimization in Heart Failure With Reduced Ejection Fraction.

Dorsch M, Sifuentes A, Cordwin D, Kuo R, Rowell B, Arzac J JACC Adv. 2024; 2(3):100289.

PMID: 38939592 PMC: 11198495. DOI: 10.1016/j.jacadv.2023.100289.


Predicting heart failure outcomes by integrating breath-by-breath measurements from cardiopulmonary exercise testing and clinical data through a deep learning survival neural network.

Ross H, Peikari M, Vishram-Nielsen J, Fan C, Hearn J, Walker M Eur Heart J Digit Health. 2024; 5(3):324-334.

PMID: 38774366 PMC: 11104469. DOI: 10.1093/ehjdh/ztae005.


The modified Rajan's heart failure risk score predicts all-cause mortality in patients hospitalized for heart failure with reduced ejection fraction: a retrospective cohort study.

Rajan R, Hui J, Al Jarallah M, Tse G, Chan J, Satti D Ann Med Surg (Lond). 2024; 86(4):1843-1849.

PMID: 38576988 PMC: 10990347. DOI: 10.1097/MS9.0000000000001646.


Exercise training outcomes in patients with chronic heart failure with reduced ejection fraction depend on patient background.

Soejima Y, Yoshioka H, Guro S, Sato H, Hatakeyama H, Sato Y Front Cardiovasc Med. 2024; 11:1330235.

PMID: 38361589 PMC: 10869166. DOI: 10.3389/fcvm.2024.1330235.


References
1.
Pfister R, Diedrichs H, Schiedermair A, Rosenkranz S, Hellmich M, Erdmann E . Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients. Eur J Heart Fail. 2008; 10(3):315-20. DOI: 10.1016/j.ejheart.2008.01.009. View

2.
OConnor C, Abraham W, Albert N, Clare R, Stough W, Gheorghiade M . Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2008; 156(4):662-73. DOI: 10.1016/j.ahj.2008.04.030. View

3.
Felker G, Leimberger J, Califf R, Cuffe M, Massie B, Adams Jr K . Risk stratification after hospitalization for decompensated heart failure. J Card Fail. 2004; 10(6):460-6. DOI: 10.1016/j.cardfail.2004.02.011. View

4.
Bobbio M, Dogliani S, Giacomarra G . Superiority of the heart failure survival score to peak exercise oxygen consumption in the prediction of outcomes in an independent population referred for heart transplant evaluation. Ital Heart J. 2005; 5(12):899-905. View

5.
ONeill J, Young J, Pothier C, Lauer M . Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers. Circulation. 2005; 111(18):2313-8. DOI: 10.1161/01.CIR.0000164270.72123.18. View